chr8-18067642-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_177924.5(ASAH1):​c.304-344G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 157,942 control chromosomes in the GnomAD database, including 14,996 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 14396 hom., cov: 30)
Exomes 𝑓: 0.42 ( 600 hom. )

Consequence

ASAH1
NM_177924.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.313

Publications

12 publications found
Variant links:
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]
ASAH1 Gene-Disease associations (from GenCC):
  • ASAH1-related sphingolipidosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Farber lipogranulomatosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • spinal muscular atrophy-progressive myoclonic epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.515 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASAH1NM_177924.5 linkc.304-344G>A intron_variant Intron 4 of 13 ENST00000637790.2 NP_808592.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASAH1ENST00000637790.2 linkc.304-344G>A intron_variant Intron 4 of 13 1 NM_177924.5 ENSP00000490272.1

Frequencies

GnomAD3 genomes
AF:
0.421
AC:
63714
AN:
151370
Hom.:
14379
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.254
Gnomad AMI
AF:
0.572
Gnomad AMR
AF:
0.524
Gnomad ASJ
AF:
0.618
Gnomad EAS
AF:
0.375
Gnomad SAS
AF:
0.516
Gnomad FIN
AF:
0.413
Gnomad MID
AF:
0.423
Gnomad NFE
AF:
0.484
Gnomad OTH
AF:
0.456
GnomAD4 exome
AF:
0.421
AC:
2716
AN:
6450
Hom.:
600
Cov.:
0
AF XY:
0.427
AC XY:
2058
AN XY:
4822
show subpopulations
African (AFR)
AF:
0.202
AC:
25
AN:
124
American (AMR)
AF:
0.523
AC:
45
AN:
86
Ashkenazi Jewish (ASJ)
AF:
0.531
AC:
17
AN:
32
East Asian (EAS)
AF:
0.399
AC:
114
AN:
286
South Asian (SAS)
AF:
0.543
AC:
88
AN:
162
European-Finnish (FIN)
AF:
0.310
AC:
26
AN:
84
Middle Eastern (MID)
AF:
0.357
AC:
10
AN:
28
European-Non Finnish (NFE)
AF:
0.424
AC:
2314
AN:
5452
Other (OTH)
AF:
0.393
AC:
77
AN:
196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
59
119
178
238
297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.421
AC:
63772
AN:
151492
Hom.:
14396
Cov.:
30
AF XY:
0.421
AC XY:
31161
AN XY:
74006
show subpopulations
African (AFR)
AF:
0.254
AC:
10499
AN:
41372
American (AMR)
AF:
0.525
AC:
7987
AN:
15216
Ashkenazi Jewish (ASJ)
AF:
0.618
AC:
2135
AN:
3452
East Asian (EAS)
AF:
0.375
AC:
1922
AN:
5124
South Asian (SAS)
AF:
0.518
AC:
2494
AN:
4814
European-Finnish (FIN)
AF:
0.413
AC:
4337
AN:
10492
Middle Eastern (MID)
AF:
0.429
AC:
126
AN:
294
European-Non Finnish (NFE)
AF:
0.484
AC:
32803
AN:
67722
Other (OTH)
AF:
0.453
AC:
950
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1797
3595
5392
7190
8987
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
598
1196
1794
2392
2990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.483
Hom.:
17010
Bravo
AF:
0.426
Asia WGS
AF:
0.410
AC:
1424
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
6.7
DANN
Benign
0.82
PhyloP100
0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12155668; hg19: chr8-17925151; API